Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

DEXCOM INC Director's Dealing 2020

Sep 17, 2020

30198_dirs_2020-09-16_85d0654e-677a-42c9-ad1b-85ba477c293d.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: DEXCOM INC (DXCM)
CIK: 0001093557
Period of Report: 2020-09-15

Reporting Person: ALTMAN STEVEN R (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2020-09-15 Common Stock S 30000 $393.92 Disposed 12980 Indirect

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 806 Direct

Footnotes

F1: The Reporting Person contributed 30,000 shares of the Issuer's Common Stock to an exchange fund in exchange for shares of the exchange fund. The Issuer's Common Stock was valued at $393.92 per share for the purpose of determining the number of shares of the exchange fund issuable to the Reporting Person. The shares contributed to the exchange fund are non-redeemable, except with the consent of the Company, for as long as the Reporting Person is a director or affiliate of the Issuer.

F2: Shares are held by the Steven R. and Lisa J. Altman, TTEE's Altman Family Trust DTD 8/21/92, with respect to which the reporting person is a trustee.